Objective Scores in Variceal Bleeding

Launched by ASSIUT UNIVERSITY · Mar 16, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well certain scoring systems can predict the outcomes for patients with liver cirrhosis who experience variceal bleeding, which is severe bleeding from enlarged veins in the esophagus or stomach. The trial will compare new scores with existing ones to see which are better at predicting early re-bleeding or death in these patients. The goal is to improve the way doctors assess and treat individuals facing this serious condition.

To participate in the trial, you need to be an adult over 18 years old with liver cirrhosis and currently experiencing variceal bleeding. However, certain patients are excluded from the study, such as those with other causes of bleeding, patients on blood-thinning medications, or those with specific types of cancer or previous surgeries related to their liver condition. If you join, you can expect thorough monitoring and evaluation to help researchers understand the effectiveness of these scoring systems, ultimately aiming to improve care for patients with similar conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any cirrhotic patients above the age of 18 years old of both sexes, present with variceal bleeding.
• Exclusion Criteria:
• • Patients with other causes of upper gastrointestinal bleeding (UGIB).
• • Patients who are receiving anticoagulant or antiplatelet therapy.
• • Patients with HCC, other malignant tumors, and hematological disease at the time of recruitment or during follow up.
• • Patients who underwent transjugular intrahepatic portosystemic shunt, splenectomy, or partial splenic embolization.
• • Patients with liver cirrhosis and portal vein thrombosis.